Abbott Laboratories (NYSE:ABT) | Abbott Labs Sued by Five Men Claiming Androgel Injuries

[at Bloomberg] – Abbott Laboratories (ABT) and AbbVie Inc., the company it spun off last year, hid the dangers of using the testosterone replacement drug AndroGel, five men claimed in lawsuits. Their complaints, . . . → Read More: Abbott Laboratories (NYSE:ABT) | Abbott Labs Sued by Five Men Claiming Androgel Injuries Similar Articles: Abbott Laboratories (NYSE:ABT) | ModernGraham Valuation Of Abbott Laboratories Company Update – Abbott Laboratories (NYSE:ABT) – Abbott Laboratories Raised Its Dividend 57%, But Is It A Buy Right Now? Abbott Laboratories (NYSE:ABT) – AbbVie Profit Beats Estimates as Sales of Humira Increase